Genfit S.A. (GNFT) Financials

Stock symbol GNFT is outdated, potentially delisted? Maybe it is available on other exchange?

GNFT Assets vs Liabilities

Date	Assets	Liabilities
June 30, 2024	209.1 million	104.6 million
March 31, 2024	210.2 million	105.1 million
Dec. 31, 2023	192.2 million	117.1 million
Sept. 30, 2023	184.1 million	112.1 million

GNFT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
June 30, 2024	-12.8 million	179274
March 31, 2024	-6.4 million	180234
Dec. 31, 2023	-34.0 million	336058
Sept. 30, 2023	-16.3 million	160913

GNFT Net Income

No data available :(

GNFT Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
June 30, 2024	66.2 million	64.2 million	6.0 million
March 31, 2024	66.5 million	64.5 million	6.1 million
Dec. 31, 2023	86.0 million	68.8 million	6.5 million
Sept. 30, 2023	82.4 million	65.9 million	6.2 million

GNFT Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
June 30, 2024	64.8 million
March 31, 2024	65.1 million
Dec. 31, 2023	54.9 million
Sept. 30, 2023	52.6 million

GNFT Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
June 30, 2024	791171	20.4 million	11.8 million	418666
March 31, 2024	397703	10.2 million	5.9 million	210453
Dec. 31, 2023	457658	27.0 million	9.0 million	393542
Sept. 30, 2023	219139	11.2 million	4.6 million	188438

GNFT Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
June 30, 2024	65.6 million	926432
March 31, 2024	33.0 million	-
Dec. 31, 2023	18.9 million	-
Sept. 30, 2023	3.0 million	-

GNFT

Price: $8.95

52 week price:

2.55

10.00

Earnings Per Share: -0.90 USD

P/E Ratio: -10.02

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 944

Market Capitalization: 449.2 million

Links:

GNFT on Yahoo Finance